Symptomatic chronic cervicitis. Endocervicitis with or without erosion or ectropion
Conditions
Interventions
Intervention 1: Intervention: Metronidazol( Alborz Darou pharmaceutical Co.)500 mg given orally twice a day until 10 days. Also cryotherapy in cervix was done with N2o(C 501, EMD Co
Tehran, Iran) until forming ice ball in position for every patient. Intervention 2: Control: Metronidazol( Alborz Darou pharmaceutical Co.)500 mg given orally twice a day until 10 days.
Intervention: Metronidazol( Alborz Darou pharmaceutical Co.)500 mg given orally twice a day until 10 days. Also cryotherapy in cervix was done with N2o(C 501, EMD Co
Tehran, Iran) until forming ice ball in position for every patient.
Control: Metronidazol( Alborz Darou pharmaceutical Co.)500 mg given orally twice a day until 10 days.
Sponsors
Vice chancellor for research, Sabzevar University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
15 Years to 55 Years
Inclusion criteria
Inclusion criteria: Inclusion: Married, Symptoms of chronic cervicitis including: Increase of vaginal discharge, pain during intercourse, vaginal itching and pruritus, age between 15-55 years old Exclusion: Acute vaginal candidiasis, menopause
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Vaginal discharge. Timepoint: One and three months after treatment. Method of measurement: ?Check list. | — |
Secondary
| Measure | Time frame |
|---|---|
| Vaginal itching and pruritus. Timepoint: 1 and 3 months after treatment. Method of measurement: Check list.;Dyspareunia. Timepoint: 1 and 3 months after treatment. Method of measurement: Check list. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactJila Agah
Sabzevar University of Medical Sciences
Outcome results
None listed